Literature DB >> 1663293

A second group of hepatitis C viruses.

K Tsukiyama-Kohara1, M Kohara, K Yamaguchi, N Maki, A Toyoshima, K Miki, S Tanaka, N Hattori, A Nomoto.   

Abstract

cDNA clone 11-7 was isolated by immunoscreening a cDNA library that was prepared from a pooled plasma of non-A non-B hepatitis (NANBH) patients using expression vector lambda gt11. This cDNA corresponds to known nucleotide positions 3983-4745 of the genome of hepatitis C virus (HCV). This clone was used as a probe for screening the HCV-related cDNAs in a cDNA library similarly prepared by using lambda gt10. As a result, six more cDNA clones were isolated and analyzed for their nucleotide sequences. The results strongly suggested that there are at least two groups of HCV, group I and group II. According to our classification, the prototype HCV and clone 11-7 belong to group I HCV, and their nucleotide and deduced amino acid sequences were diverged from those of group II HCV. Genetic variation observed in the nucleotide and the amino acid sequences between the two groups resembles that in the NS3 region of the genome between Japanese encephalitis virus and West Nile fever virus. Polypeptides produced in Escherichia coli carrying a clone 11-7 or a group II cDNA clone E reacted with antibodies in the blood of 12 or 4 out of 14 individual chronic NANBH patients, respectively. Our data clearly indicate the existence of a second group of HCV.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663293     DOI: 10.1007/bf00568974

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  22 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

3.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

4.  Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B.

Authors:  E A Fagan; D S Ellis; G M Tovey; G Lloyd; B Portmann; R Williams; A J Zuckerman
Journal:  J Med Virol       Date:  1989-07       Impact factor: 2.327

5.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

6.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.

Authors:  R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

8.  Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process.

Authors:  S Aihara; C M Rao; Y X Yu; T Lee; K Watanabe; T Komiya; H Sumiyoshi; H Hashimoto; A Nomoto
Journal:  Virus Genes       Date:  1991-04       Impact factor: 2.332

9.  Transmission of non-A, non-B hepatitis from man to chimpanzee.

Authors:  E Tabor; R J Gerety; J A Drucker; L B Seeff; J H Hoofnagle; D R Jackson; M April; L F Barker; G Pineda-Tamondong
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

10.  Hepatitis B virus, hepatitis non-A, non-B virus and hepatitis delta virus in lyophilized antihemophilic factor: relative sensitivity to heat.

Authors:  R H Purcell; J L Gerin; H Popper; W T London; J Cicmanec; J W Eichberg; J Newman; M E Hrinda
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

View more
  20 in total

1.  Use of a novel hepatitis C virus (HCV) major-epitope chimeric polypeptide for diagnosis of HCV infection.

Authors:  D Y Chien; P Arcangel; A Medina-Selby; D Coit; M Baumeister; S Nguyen; C George-Nascimento; A Gyenes; G Kuo; P Valenzuela
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.

Authors:  Vinod Kumar; Naoya Kato; Yuji Urabe; Atsushi Takahashi; Ryosuke Muroyama; Naoya Hosono; Motoyuki Otsuka; Ryosuke Tateishi; Masao Omata; Hidewaki Nakagawa; Kazuhiko Koike; Naoyuki Kamatani; Michiaki Kubo; Yusuke Nakamura; Koichi Matsuda
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

3.  Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.

Authors:  N Izumi; H Kumada; N Hashimoto; H Harada; M Imawari; M Zeniya; G Toda
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

4.  Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

Authors:  A Matsumoto; E Tanaka; T Suzuki; H Ogata; K Kiyosawa
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

Review 5.  Recent advances in hepatitis C virus research.

Authors:  M Omata; N Kato
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

6.  Prevalence of HCV genotype among patients with chronic liver diseases in the Tokyo metropolitan area.

Authors:  M Kobayashi; H Kumada; K Chayama; Y Arase; S Saitou; A Tsubota; I Koida; K Ikeda; M Hashimoto; S Iwasaki
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

7.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.

Authors:  P Simmonds; K A Rose; S Graham; S W Chan; F McOmish; B C Dow; E A Follett; P L Yap; H Marsden
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.

Authors:  N Kato; H Sekiya; Y Ootsuyama; T Nakazawa; M Hijikata; S Ohkoshi; K Shimotohno
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  At least five related, but distinct, hepatitis C viral genotypes exist.

Authors:  T A Cha; E Beall; B Irvine; J Kolberg; D Chien; G Kuo; M S Urdea
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: correlation with genotypes.

Authors:  J H Kao; H H Lin; P J Chen; M Y Lai; T H Wang; M Mizokami; D S Chen
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.